Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

VTA real-time biofeedback with 7-Tesla MRI in depression

Official title: Mechanisms of Repeated Real-time Biofeedback With 7-Tesla MRI in Depression

Run by University of Oxford · NCT07694076 · Data updated 2026-11-12

This study tests whether people with major depressive disorder can learn to modulate their brain's reward center (the VTA) using real-time feedback during 7-Tesla MRI sessions, to see if it changes mood and motivation.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of Oxford
Academic / other
Locations1 site (Oxford)
StatusRecruiting
StartedDecember 2026
Main results expectedJune 2031
Study endsJune 2033
Registry record updatedNovember 3, 2026
Trial IDNCT07694076 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-65 with a current major depressive episode meeting DSM-5 criteria, able to participate in MRI procedures and English-language assessments.

Probably not a fit

Individuals with contraindications to MRI, recent antidepressant changes, or significant comorbidities may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This mechanistic study will enroll 60 adults with major depressive disorder and randomize them to active or sham real-time biofeedback while they attempt to self-regulate ventral tegmental area activity using cognitive strategies during 7T MRI sessions. Participants will complete two training sessions with feedback while viewing visual cues, aiming to characterize changes in mood, motivation-related measures, and neural connectivity. The trial builds on prior work showing VTA self-regulation is feasible and seeks to clarify relationships between targeted VTA modulation and clinical/neural outcomes in a larger sample. Outcomes will include mood and motivation scales as well as fMRI-derived measures of brain activity and functional connectivity.

Why it matters

Potential benefit: If successful, the approach could provide a new, mechanism-based option for targeting motivation and reward-related symptoms in depression.

How similar studies have gone: Prior work has shown feasibility of VTA self-regulation with real-time feedback, supporting the potential for benefit in this larger, repeated-training study.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female aged 18-65 years;
* Meets DSM-5 criteria for major depressive disorder (MDD) as determined by the Structured Clinical Interview for DSM-5 Axis Disorders (SCID) or the Mini International Neuropsychiatric Interview (MINI); with a current major depressive episode; as conducted in a research-based non-clinical setting.
* Participants must have a level of understanding of the English language sufficient to agree to all tests and examinations required by the study and must be able to participate fully in the informed consent process.

Exclusion Criteria:

* Current or history of schizophrenia or other psychotic disorder, neurodevelopmental disorder, neurocognitive disorder or cognitive impairment
* Active substance use disorder within the past 1 year;
* Any unstable medical illnesses;
* Women who are pregnant;
* Any contraindications to MRI
* Antidepressant medication initiated within 2 weeks of the Baseline Assessment and concomitant use of any other medication with central nervous system activity during active participation;
* Active suicidal intent or plan.

Where it's running

  • Oxford Centre for Integrative Neuroimaging (OxCIN) FMRIB, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital
    Oxford, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.